Advertisement

Topic: M. D. Anderson

Jump to

Latest Headlines

Science News // 1 decade ago

New B cell lymphoma therapy is presented

U.S. medical scientists say they've found indolent B cell lymphoma patients respond well to a new three-drug combination therapy.

Health News // 1 decade ago

Supplements don't prevent prostate cancer

Selenium and vitamin E taken alone or in combination for an average of 5 1/2 years did not prevent prostate cancer, U.S. researchers said.

Health News // 1 decade ago

Diet, exercise help old cancer survivors

A portion-controlled diet and exercise improve body weight and physical function in elderly cancer survivors, U.S. researchers have learned.

Science News // 1 decade ago

Genes may alter esophageal cancer risk

U.S. cancer scientists say they have found variations in a common gene pathway can affect esophageal cancer risk.

Science News // 1 decade ago

New cancer drug is called impressive

U.S. scientists say an early trial of a multi-kinase inhibitor has shown impressive tumor shrinkage in patients with a hard-to-treat form of thyroid cancer.

Science News // 1 decade ago

New delivery system hikes vaccine response

U.S. scientists say they've developed a delivery system that could lead to more efficient and more disease-specific vaccines.

Health News // 1 decade ago

No radiation for some breast cancer

Early-stage breast cancer patients with limited lymph node involvement may not require post-surgery radiation therapy, U.S. researchers said.

Health News // 1 decade ago

Non-invasive bladder cancer test uses gene

Counting the copies of a specific gene in cells from a urine sample may provide a simple, non-invasive way to detect bladder cancer, U.S. researchers said.

Health News // 1 decade ago

Black women less likely to get radiation

African-American women with breast cancer who have a lumpectomy are less likely to receive radiation compared to white women, U.S. researchers said.

Science News // 1 decade ago

Protein found to suppress skin cancer

U.S. scientists say they've determined the protein IKKalpha suppresses skin cancer development.

The University of Texas M. D. Anderson Cancer Center is one of the nation's original three comprehensive cancer centers established by the National Cancer Act of 1971. It is both a degree-granting academic institution and a cancer treatment and research center located in the Texas Medical Center in Houston, Texas. For six of the past eight years, M. D. Anderson has ranked No. 1 in cancer care in the "America's Best Hospitals" survey published in U.S. News & World Report.

M. D. Anderson was created by an act of the Texas Legislature in 1941, making it a component of The University of Texas System. Today it is one of 40 Comprehensive Cancer Centers designated by the National Cancer Institute. The cancer center expects to see more than 90,000 patients this year and employs more than 17,000 people.

The cancer center is named after Monroe Dunaway Anderson, a banker and cotton trader from Jackson, Tennessee. He was a member of a business partnership with his brother-in-law Will Clayton. Their company became the largest cotton company in the world. Anderson feared that, in the event of one of the partners' deaths, the company would lose a large amount of money to estate tax and be forced to dissolve. To avoid this, Anderson created the M.D. Anderson Foundation with an initial sum of $300,000. In 1939 after Anderson's death, the foundation received $19 million.

FULL ARTICLE AT WIKIPEDIA.ORG

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "M. D. Anderson."